Evidence map›Paper›PMID 21159874›Full record

ArticleJournal of virology2011

Inhibition of early stages of HIV-1 assembly by INI1/hSNF5 transdominant negative mutant S6.

Jennifer Cano, Ganjam V Kalpana

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Computational modeling of Repeat1 region of INI1/hSNF5: An evolutionary link with ubiquitin.Protein science : a publication of the Protein Society · 2016
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Integrating the HIV-1 assembly/maturation pathway.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  15. HIV integrase inhibitors: 20-year landmark and challenges.Advances in pharmacology (San Diego, Calif.) · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jennifer CanoDepartment of Genetics, Albert Einstein College of Medicine, Bronx, NY 1046, USA.
Ganjam V Kalpana
Albert Einstein College of Medicine · US

Funding

Training in HIV/AIDS Pathogenesis; Basic and Translational ResearchT32AI007501 · NIAID · YESHIVA UNIVERSITY · PI PRASAD, VINAYAKA R. · 1995 to 2024
$6.6M
PROTEIN/PROTEIN INTERACTIONS OF HIV-1 INTEGRASER01AI039951 · NIAID · YESHIVA UNIVERSITY · PI KALPANA, GANJAM V · 1996 to 2006
$2.3M
NIAID NIH HHS R01 AI039951NIAID NIH HHS T32 AI007501NIAID NIH HHS T32-AI007501
6 · The paper itself

Abstract

INI1/hSNF5 is an HIV-1 integrase (IN) binding protein specifically incorporated into virions. A truncated mutant of INI1 (S6, amino acids 183 to 294) harboring the minimal IN binding Rpt1 domain potently inhibits HIV-1 particle production in a transdominant manner. The inhibition requires interaction of S6 with IN within Gag-Pol. While INI1 is a nuclear protein and harbors a masked nuclear export signal (NES), the transdominant negative mutant S6 is cytoplasmic, due to the unmasking of NES. Here, we examined the effects of subcellular localization of S6 on HIV-1 inhibition and further investigated the stages of assembly that are affected. We found that targeting a nuclear localization signal-containing S6 variant [NLS-S6(Rpt1)] to the nucleoplasm (but not to the nucleolus) resulted in complete reversal of inhibition of particle production. Electron microscopy indicated that although no electron-dense particles at any stage of assembly were seen in cells expressing S6, virions were produced in cells expressing the rescue mutant NLS-S6(Rpt1) to wild-type levels. Immunofluorescence analysis revealed that p24 exhibited a diffuse pattern of localization within the cytoplasm in cells expressing S6 in contrast to accumulation along the membrane in controls. Pulse-chase analysis indicated that in S6-expressing cells, although Gag(Pr55(gag)) protein translation was unaffected, processing and release of p24 were defective. Together, these results indicate that expression of S6 in the cytoplasm interferes with trafficking of Gag-Pol/Gag to the membrane and causes a defective processing leading to inhibition of assembly at an early stage prior to particle formation and budding.

Indexed as

MutationVirus AssemblyAmino Acid MotifsAmino Acid SequenceCell LineChromosomal Proteins, Non-HistoneDNA-Binding ProteinsHIV-1HIV InfectionsHIV IntegraseHumansMolecular Sequence DataNuclear Localization SignalsProtein BindingProtein TransportSMARCB1 ProteinChromosomal Proteins, Non-HistoneDNA-Binding ProteinsHIV IntegraseNuclear Localization SignalsSMARCB1 ProteinSMARCB1 protein, humanTranscription Factors

Identifiers

PMID21159874
PMCPMC3067803
OpenAlexW2081466989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.